-
Product Insights
Cf & I Pit Mine
The Cf & I Pit Mine is a iron ore mine in United States. It is currently in operation. Empower your strategies with our Cf & I Pit Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability...
-
Product Insights
CFS Alarcos Solar PV Park
CFS Alarcos Solar PV Park is a solar PV project located in Castile-La Mancha, Spain. The project is owned by China Three Gorges Corp and was developed by Innogy SE; Photosolar Medina 4 SL; Synergia Energy Solutions SL; X-ELIO Energy SL. The project came online in 2019. Empower your strategies with our CFS Alarcos Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval Analysis for Cystic Fibrosis
Overview How likely is it that the drugs in Cystic Fibrosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cystic Fibrosis Overview Cystic fibrosis (CF) is an inherited disease that causes...
-
Company Insights
Innovation and Patenting activity of CF Industries Holdings Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of CF Industries Holdings Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – RCT-2100 in Cystic Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RCT-2100 in Cystic Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RCT-2100 in Cystic Fibrosis Drug Details: RCT-2100 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – APPA-02 in Cystic Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - APPA-02 in Cystic Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. APPA-02 in Cystic Fibrosis Drug Details: APPA-02 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – APPA-02 in Resistant Pseudomonas aeruginosa Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - APPA-02 in Resistant Pseudomonas aeruginosa Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. APPA-02 in Resistant Pseudomonas aeruginosa Infections Drug Details: APPA-02 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Luveltamab Tazevibulin in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Luveltamab Tazevibulin in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Luveltamab Tazevibulin in Endometrial Cancer Drug Details: STRO-002 is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – STRO-001 in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - STRO-001 in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. STRO-001 in Diffuse Large B-Cell Lymphoma Drug Details: STRO-001 is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – STRO-001 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - STRO-001 in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. STRO-001 in Mantle Cell Lymphoma Drug Details: STRO-001 is under development...